Protagonist Therapeutics, Inc (ticker: PTGX) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of PTGX's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. PTGX reported $8.78M in revenue and $3.78M for the period ending 2017-09-30, with operating cash flow of -$48.94M. Cash and equivalents stood at $193.71M (up 38.7% year-over-year). Total assets of $697.46M exceed total liabilities of $41.99M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
PTGX Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Protagonist Therapeutics, Inc (PTGX) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.